Scholz C - Search Results

1

The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.

Liu H, Zang C, Schefe JH, Schwarzlose-Schwarck S, Regierer AC, Elstner E, Schulz CO, Scholz C, Possinger K, Eucker J. Liu H, et al. Among authors: scholz c. Anticancer Res. 2011 Sep;31(9):2713-22. Anticancer Res. 2011. PMID: 21868512

2

Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.

Zang C, Eucker J, Liu H, Müller A, Possinger K, Scholz CW. Zang C, et al. Among authors: scholz cw. Cancer Lett. 2013 Oct 10;339(2):288-97. doi: 10.1016/j.canlet.2012.11.013. Epub 2012 Nov 27. Cancer Lett. 2013. PMID: 23200668

3

Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma.

Zang C, Eucker J, Liu H, Coordes A, Lenarz M, Possinger K, Scholz CW. Zang C, et al. Among authors: scholz cw. Leuk Lymphoma. 2014 Feb;55(2):425-34. doi: 10.3109/10428194.2013.806800. Epub 2013 Jul 25. Leuk Lymphoma. 2014. PMID: 23721513

4

Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer.

Habbel P, Kurreck A, Schulz CO, Regierer AC, Kaul D, Scholz CW, Neumann C, Possinger K, Eucker J. Habbel P, et al. Among authors: scholz cw. Anticancer Res. 2015 Sep;35(9):5091-5. Anticancer Res. 2015. PMID: 26254412

5

The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trial.

Schwarzlose-Schwarck S, Scholz CW, Regierer AC, Martus P, Neumann C, Habbel P, Liu H, Zang C, Schefe JH, Schulz CO, Possinger K, Eucker J. Schwarzlose-Schwarck S, et al. Among authors: scholz cw. Anticancer Res. 2012 Aug;32(8):3435-41. Anticancer Res. 2012. PMID: 22843927 Clinical Trial.

6

TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic leukemia in vitro.

Eucker J, Zang C, Zhou Y, Li X, Habbel P, Schulz CO, Scholz C, Liu H. Eucker J, et al. Among authors: scholz c. Anticancer Res. 2014 Sep;34(9):4899-907. Anticancer Res. 2014. PMID: 25202072

7

The multi-tyrosine kinase inhibitor TKI258, alone or in combination with RAD001, is effective for treatment of human leukemia with BCR-ABL translocation in vitro.

Eucker J, Zang C, Zhou Y, Li X, Habbel P, Neumann C, Scholz C, Liu H. Eucker J, et al. Among authors: scholz c. Anticancer Res. 2014 Sep;34(9):4909-14. Anticancer Res. 2014. PMID: 25202073

8

Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.

Liu H, Scholz C, Zang C, Schefe JH, Habbel P, Regierer AC, Schulz CO, Possinger K, Eucker J. Liu H, et al. Among authors: scholz c. Anticancer Res. 2012 May;32(5):1627-37. Anticancer Res. 2012. PMID: 22593441

9

Primary tumor excision in stage IV breast cancer at diagnosis without influence on survival: a retrospective analysis and review of the literature.

Rosche M, Regierer AC, Schwarzlose-Schwarck S, Weigel A, Bangemann N, Schefe JH, Scholz CW, Possinger K, Eucker J. Rosche M, et al. Onkologie. 2011;34(11):607-12. doi: 10.1159/000334061. Epub 2011 Oct 28. Onkologie. 2011. PMID: 22104157 Review.

10

Breast Cancer-Associated Thrombotic Microangiopathy.

Regierer AC, Kuehnhardt D, Schulz CO, Flath B, Jehn CF, Scholz CW, Possinger K, Eucker J. Regierer AC, et al. Among authors: scholz cw. Breast Care (Basel). 2011 Dec;6(6):441-445. doi: 10.1159/000335201. Epub 2011 Dec 15. Breast Care (Basel). 2011. PMID: 22419897 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

661 results

Search Page

Filters